US 11,925,512 B2
Methods and systems for controlled deployment of needles in tissue
Michael Munrow, Belmont, CA (US); Jordan Bajor, Palo Alto, CA (US); and Malcolm G. Munro, Tarzana, CA (US)
Assigned to Gynesonics, Inc., Redwood City, CA (US)
Filed by Gynesonics, Inc., Redwood City, CA (US)
Filed on Jul. 14, 2021, as Appl. No. 17/376,039.
Application 17/376,039 is a continuation of application No. 17/028,596, filed on Sep. 22, 2020, granted, now 11,096,761.
Application 17/028,596 is a continuation of application No. 15/595,659, filed on May 15, 2017.
Application 15/595,659 is a continuation of application No. 13/589,975, filed on Aug. 20, 2012, abandoned.
Application 13/589,975 is a continuation of application No. 13/307,304, filed on Nov. 30, 2011, granted, now 8,262,577, issued on Sep. 11, 2012.
Application 13/307,304 is a continuation of application No. 12/245,567, filed on Oct. 3, 2008, granted, now 8,088,072, issued on Jan. 3, 2012.
Claims priority of provisional application 60/979,613, filed on Oct. 12, 2007.
Prior Publication US 2021/0338365 A1, Nov. 4, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 90/00 (2016.01); A61B 8/08 (2006.01); A61B 8/12 (2006.01); A61B 10/00 (2006.01); A61B 18/14 (2006.01); A61M 5/46 (2006.01); A61B 10/04 (2006.01); A61B 34/10 (2016.01); A61B 90/11 (2016.01)
CPC A61B 90/36 (2016.02) [A61B 8/0841 (2013.01); A61B 8/12 (2013.01); A61B 10/0045 (2013.01); A61B 18/1477 (2013.01); A61M 5/46 (2013.01); A61B 2010/045 (2013.01); A61B 2018/1425 (2013.01); A61B 2034/107 (2016.02); A61B 90/11 (2016.02); A61B 2090/378 (2016.02)] 27 Claims
OG exemplary drawing
 
1. A system for treating uterine anatomy, the system comprising:
a radiofrequency ablation device comprising a needle array comprising multiple needles, wherein the needle array is deployable into a uterine fibroid;
a radiofrequency generator; and
a processing unit programmed to:
display, on a screen, a real-time image of the uterine anatomy including a uterine fibroid to be treated;
overlay, onto the real-time image, a projected path of the radiofrequency ablation device;
overlay, onto the real-time image, a projected treatment boundary based on a first, actual position of the needle array prior to deployment of the needle array into the uterine fibroid;
recalculate the projected treatment boundary based on a second, actual position of the needle array after deployment of the needle array into the uterine fibroid;
overlay, onto the real-time image, the recalculated projected treatment boundary; and
deliver radiofrequency energy from the radiofrequency generator through the needle array to treat the uterine fibroid after recalculating the projected treatment boundary and with at least a portion of the uterine fibroid positioned within the recalculated projected treatment boundary on the real-time image.